Technical Analysis for PRE - Prenetics Global Limited
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Strong | Up | Up | Up |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| 1,2,3 Pullback Bullish | Bullish Swing Setup | 0.00% | |
| Non-ADX 1,2,3,4 Bullish | Bullish Swing Setup | 0.00% | |
| Narrow Range Bar | Range Contraction | 0.00% | |
| Wide Bands | Range Expansion | 0.00% | |
| Overbought Stochastic | Strength | 0.00% | |
| Down 3 Days in a Row | Weakness | 0.00% | |
| Down 4 Days in a Row | Weakness | 0.00% | |
| NR7 | Range Contraction | -0.79% | |
| NR7-2 | Range Contraction | -0.79% | |
| Narrow Range Bar | Range Contraction | -0.79% |
| Alert | Time |
|---|---|
| Fell Below Previous Day's Low | 1 day ago |
| Down 1% | 1 day ago |
| 60 Minute Opening Range Breakdown | 2 days ago |
| Down 2 % | 2 days ago |
| Fell Below Previous Day's Low | 2 days ago |
Get a Trading Sidekick!
- Earnings date: 03/12/2024
Prenetics Global Limited Description
Prenetics Limited, a DNA biotechnology company, specializes in pharmacogenomics. The company develops iGenes PGx test that enables physicians to help patients identify the right drug, right dosage, and to list out potential adverse drug effects based on one's genetic profile. Its iGenes PGx test is used to test cardiovascular, psychiatric, pain, hypersensitivity, and commonly prescribed drugs. The company also offers ONEdna, a DNA screening test service that provides a view and analysis of an individual's genes along with actionable recommendations. The company has strategic partnerships with The Lippo Group and New Horizon Health Limited. Prenetics Limited was formerly known as Multigene Diagnostics Limited and changed its name to Prenetics Limited in November 2014. The company was incorporated in 2007 and is based in Central, Hong Kong.
Classification
Sector: Healthcare
Industry: Diagnostics & Research
Keywords: Biotechnology Life Sciences Health Sciences Pain Pharmacy Genomics Pharmacology Medical Genetics Medical Test Genetic Testing Pharmacogenomics
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 15.0 |
| 52 Week Low | 2.85 |
| Average Volume | 139,495 |
| 200-Day Moving Average | 5.64 |
| 50-Day Moving Average | 4.57 |
| 20-Day Moving Average | 5.26 |
| 10-Day Moving Average | 5.76 |
| Average True Range | 0.54 |
| RSI (14) | 60.47 |
| ADX | 45.36 |
| +DI | 36.43 |
| -DI | 13.73 |
| Chandelier Exit (Long, 3 ATRs) | 6.22 |
| Chandelier Exit (Short, 3 ATRs) | 4.47 |
| Upper Bollinger Bands | 6.52 |
| Lower Bollinger Band | 4.00 |
| Percent B (%b) | 0.71 |
| BandWidth | 48.03 |
| MACD Line | 0.46 |
| MACD Signal Line | 0.41 |
| MACD Histogram | 0.0545 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 6.13 | ||||
| Resistance 3 (R3) | 6.13 | 6.03 | 6.08 | ||
| Resistance 2 (R2) | 6.03 | 5.94 | 6.03 | 6.06 | |
| Resistance 1 (R1) | 5.92 | 5.89 | 5.97 | 5.91 | 6.04 |
| Pivot Point | 5.81 | 5.81 | 5.84 | 5.81 | 5.81 |
| Support 1 (S1) | 5.70 | 5.72 | 5.75 | 5.69 | 5.57 |
| Support 2 (S2) | 5.59 | 5.67 | 5.59 | 5.55 | |
| Support 3 (S3) | 5.48 | 5.59 | 5.53 | ||
| Support 4 (S4) | 5.48 |
